The list below is a sampling of the many open BMT clinical trials for CLL at University of Minnesota Medical Center. We will be adding protocol summaries in the future, so please be sure to visit us again. For information on additional trials, please call 612-273-2800.

Allogeneic Transplant for Hematologic Malignancy (MT2001-02)

Reduced Intensity Allo Bone Marrow Transplant (MT 2001-10)

Myeloablative UCB Transplant for Heme Malignancy (MT2005-10)

Reduced Intensity UCB Transplant (MT 2005-02)

Unrelated or Partially Related Donor Transplant for NHL, Myeloma and CLL (MT1999-14)

Expanded Human Myeloid Progenitor Cells Post Allo Umbilical Cord Transplant for Heme Malignancy (MT2008-38)

UCB Tregs after Reduced Intensity Transplant (MT 2006-01)

Reduced Intensity UCB Transplant with C3a Priming (MT 2008-15)

Revlimid vs. Chlorambucil for Untreated CLL in Elderly Patients (MT 2009-11)

Non-Myeloablative Conditioning with Pentostatin, Rituximab and Ontek plus NK cells for Refractory NHL & CLL (MT 2009-15)